Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer now shows Revision: v3.4.2 instead of v3.4.1; no study details or content have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1 in the footer, indicating a small site update without changes to the study information.SummaryDifference0.1%

- Check27 days agoChange DetectedUI/documentation updates include a glossary feature and updated metadata labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Ottawa, Ontario, Canada as a study site and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedThe page revision tag changed from v3.2.0 to v3.3.2. This appears to be an internal version update and does not affect study information.SummaryDifference0.1%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.